Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfred J Saah

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Lancet (London, England)|March 21, 2021
Control vaccine formulation - Authors' replyAlfred J Saah, Nubia Muñoz
Current Topics in Microbiology and Immunology|February 15, 2026
HPV Type Replacement After HPV VaccinationElizabeth M Anderson, Alfred J Saah, Joseph E Tota
The Journal of Infection|March 23, 2005
Salvage therapy with caspofungin for invasive aspergillosis: results from the caspofungin compassionate use studyNicholas A Kartsonis, Alfred J Saah, C Joy Lipka, et al.
Vaccine|September 13, 2023
Prophylactic HPV vaccines in patients with HPV-associated diseases and cancerMiriam Reuschenbach, John Doorbar, Marta Del Pino, et al.
The American Journal of Tropical Medicine and Hygiene|August 5, 2011
Placental malaria and mother-to-child transmission of human immunodeficiency virus-1 in rural RwandaPhilip L Bulterys, Ann Chao, Sudeb C Dalai, et al.
Vaccine|March 22, 2012
Safety and immunogenicity of a vaccine targeting human papillomavirus types 6, 11, 16 and 18: a randomized, double-blind, placebo-controlled trial in Chinese males and femalesRongcheng Li, Yanping Li, David Radley, et al.
Contemporary Clinical Trials|April 5, 2020
Use of real-world data for HPV vaccine trial follow-up in the Nordic regionEspen Enerly, Sophie Berger, Susanne K Kjær, et al.
Vaccine|February 28, 2017
Four-year persistence of type-specific immunity after quadrivalent human papillomavirus vaccination in HIV-infected children: Effect of a fourth dose of vaccineMyron J Levin, Sharon Huang, Anna-Barbara Moscicki, et al.
Vaccine|August 21, 2018
Efficacy of quadrivalent human papillomavirus vaccine against persistent infection and genital disease in Chinese women: A randomized, placebo-controlled trial with 78-month follow-upLihui Wei, Xing Xie, Jihong Liu, et al.
International Journal of Cancer|September 15, 2025
Epidemiological approaches to evaluate clinical unmasking of HPV-associated cervical lesions in the HPV vaccination eraJoseph E Tota, Jaimie Z Shing, Jeffrey N Roberts, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Lancet (London, England)|March 21, 2021
Control vaccine formulation - Authors' replyAlfred J Saah, Nubia Muñoz
Current Topics in Microbiology and Immunology|February 15, 2026
HPV Type Replacement After HPV VaccinationElizabeth M Anderson, Alfred J Saah, Joseph E Tota
The Journal of Infection|March 23, 2005
Salvage therapy with caspofungin for invasive aspergillosis: results from the caspofungin compassionate use studyNicholas A Kartsonis, Alfred J Saah, C Joy Lipka, et al.
Vaccine|September 13, 2023
Prophylactic HPV vaccines in patients with HPV-associated diseases and cancerMiriam Reuschenbach, John Doorbar, Marta Del Pino, et al.
The American Journal of Tropical Medicine and Hygiene|August 5, 2011
Placental malaria and mother-to-child transmission of human immunodeficiency virus-1 in rural RwandaPhilip L Bulterys, Ann Chao, Sudeb C Dalai, et al.
Vaccine|March 22, 2012
Safety and immunogenicity of a vaccine targeting human papillomavirus types 6, 11, 16 and 18: a randomized, double-blind, placebo-controlled trial in Chinese males and femalesRongcheng Li, Yanping Li, David Radley, et al.
Contemporary Clinical Trials|April 5, 2020
Use of real-world data for HPV vaccine trial follow-up in the Nordic regionEspen Enerly, Sophie Berger, Susanne K Kjær, et al.
Vaccine|February 28, 2017
Four-year persistence of type-specific immunity after quadrivalent human papillomavirus vaccination in HIV-infected children: Effect of a fourth dose of vaccineMyron J Levin, Sharon Huang, Anna-Barbara Moscicki, et al.
Vaccine|August 21, 2018
Efficacy of quadrivalent human papillomavirus vaccine against persistent infection and genital disease in Chinese women: A randomized, placebo-controlled trial with 78-month follow-upLihui Wei, Xing Xie, Jihong Liu, et al.
International Journal of Cancer|September 15, 2025
Epidemiological approaches to evaluate clinical unmasking of HPV-associated cervical lesions in the HPV vaccination eraJoseph E Tota, Jaimie Z Shing, Jeffrey N Roberts, et al.
Pageof 3